Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Carbamazepine is a prescription anticonvulsant used for selected seizure disorders and pain from true trigeminal neuralgia. Oral forms include conventional tablets, chewable tablets, suspension, and extended-release products. It is not a simple pain reliever and does not control absence seizures. Dosing depends on age, formulation, indication, treatment response, and interacting medicines.
read more about carbamazepine ...The exact mechanism of carbamazepine remains unknown. Experimental data show reduced polysynaptic responses and blocked post-tetanic potentiation, actions associated with anticonvulsant activity. Carbamazepine and its active epoxide metabolite can reduce excessive neuronal activity, though the clinical contribution of the metabolite is not fully established.
Carbamazepine is indicated for partial seizures with complex symptoms, generalized tonic-clonic seizures, and mixed seizure patterns that include these seizure types. It is also indicated for pain from true trigeminal neuralgia. Beneficial results have been reported in glossopharyngeal neuralgia. Absence seizures are not controlled by carbamazepine.
For epilepsy in patients older than 12, conventional tablets commonly start at 200 mg twice daily and increase gradually according to response. Adults rarely need more than 1600 mg daily. Trigeminal neuralgia starts at 100 mg twice daily and can increase by up to 200 mg daily, with a 1200 mg daily maximum.
Carbamazepine carries boxed warnings for serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, and for aplastic anemia and agranulocytosis. HLA-B*1502 testing is recommended before treatment in genetically at-risk populations. Other concerns include low sodium, liver injury, suicidal thoughts or behavior, blood disorders, and serious drug interactions.
Carbamazepine treats selected partial, generalized tonic-clonic, and mixed seizure patterns.
No. Current labeling states that absence seizures do not appear to be controlled by carbamazepine.
Yes. Carbamazepine is indicated for pain associated with true trigeminal neuralgia.
Yes. Boxed warnings cover serious dermatologic reactions and the risks of aplastic anemia and agranulocytosis.
Carbamazepine. MedlinePlus. https://www.medlineplus.gov/druginfo/meds/a682237.html. Date Accessed September 21, 2026.
Carbamazepine. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/carbamazepine. Date Accessed September 21, 2026.
Carbamazepine. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK482455/. Date Accessed September 21, 2026.
DailyMed - CARBAMAZEPINE tablet. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ce5aec7a-e161-46bf-8fc0-afb41689e59a. Date Accessed September 21, 2026.
DailyMed - CARBAMAZEPINE tablet, extended release. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2e3c4854-89a1-4e3f-88d4-e164829585fb. Date Accessed September 21, 2026.